We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma.
- Authors
Hussein, Mohamad A; Baz, Rachid; Srkalovic, Gordan; Agrawal, Neeraj; Suppiah, Revathi; Hsi, Eric; Andresen, Steven; Karam, Mary Ann; Reed, Janice; Faiman, Beth; Kelly, Megan; Walker, Esteban
- Abstract
To evaluate the efficacy and safety of adding thalidomide to the pegylated liposomal doxorubicin, vincristine, and decreased-frequency dexamethasone (DVd) regimen for multiple myeloma.
- Publication
Mayo Clinic proceedings, 2006, Vol 81, Issue 7, p889
- ISSN
0025-6196
- Publication type
Journal Article
- DOI
10.4065/81.7.889